On comparing serum chemerin levels in 189 patients with NSCLC compared to healthy controls, Xu et al. showed that serum chemerin levels were increased in patients with NSCLC compared to controls, with a level of chemerin over 1500 ng/mL being able to be used as a discriminating value [39]. The gene discussed is RARRES2; the disease is non-small cell lung carcinoma.